223 related articles for article (PubMed ID: 30131802)
1. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
Front Immunol; 2018; 9():1761. PubMed ID: 30131802
[TBL] [Abstract][Full Text] [Related]
2. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
[TBL] [Abstract][Full Text] [Related]
4. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
6. T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent
Lopez-Ocasio M; Buszko M; Blain M; Wang K; Shevach EM
Front Immunol; 2020; 11():637. PubMed ID: 32362895
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity in hyper-IgM syndrome.
Jesus AA; Duarte AJ; Oliveira JB
J Clin Immunol; 2008 May; 28 Suppl 1():S62-6. PubMed ID: 18246414
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
Lee WI; Torgerson TR; Schumacher MJ; Yel L; Zhu Q; Ochs HD
Blood; 2005 Mar; 105(5):1881-90. PubMed ID: 15358621
[TBL] [Abstract][Full Text] [Related]
10. The hyper IgM syndrome--an evolving story.
Etzioni A; Ochs HD
Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
[TBL] [Abstract][Full Text] [Related]
11. Respiratory Complications in Patients with Hyper IgM Syndrome.
Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
[TBL] [Abstract][Full Text] [Related]
12. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.
Longo NS; Lugar PL; Yavuz S; Zhang W; Krijger PH; Russ DE; Jima DD; Dave SS; Grammer AC; Lipsky PE
Blood; 2009 Apr; 113(16):3706-15. PubMed ID: 19023113
[TBL] [Abstract][Full Text] [Related]
13. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
[TBL] [Abstract][Full Text] [Related]
14. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N
Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148
[TBL] [Abstract][Full Text] [Related]
15. Circulating follicular T helper cells are possibly associated with low levels of serum immunoglobulin G due to impaired immunoglobulin class-switch recombination of B cells in children with primary nephrotic syndrome.
Yang X; Tang X; Li T; Man C; Yang X; Wang M; Zhang G; Chen Y; Yang H; Li Q
Mol Immunol; 2019 Oct; 114():162-170. PubMed ID: 31352232
[TBL] [Abstract][Full Text] [Related]
16. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
[TBL] [Abstract][Full Text] [Related]
17. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
18. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
19. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies.
Ma CS; Wong N; Rao G; Avery DT; Torpy J; Hambridge T; Bustamante J; Okada S; Stoddard JL; Deenick EK; Pelham SJ; Payne K; Boisson-Dupuis S; Puel A; Kobayashi M; Arkwright PD; Kilic SS; El Baghdadi J; Nonoyama S; Minegishi Y; Mahdaviani SA; Mansouri D; Bousfiha A; Blincoe AK; French MA; Hsu P; Campbell DE; Stormon MO; Wong M; Adelstein S; Smart JM; Fulcher DA; Cook MC; Phan TG; Stepensky P; Boztug K; Kansu A; İkincioğullari A; Baumann U; Beier R; Roscioli T; Ziegler JB; Gray P; Picard C; Grimbacher B; Warnatz K; Holland SM; Casanova JL; Uzel G; Tangye SG
J Allergy Clin Immunol; 2015 Oct; 136(4):993-1006.e1. PubMed ID: 26162572
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.
Dahlberg CI; He M; Visnes T; Torres ML; Cortizas EM; Verdun RE; Westerberg LS; Severinson E; Ström L
J Immunol; 2014 Nov; 193(9):4732-8. PubMed ID: 25252954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]